Abstract 754: Development of death receptor agonists for breast cancer therapy

Mapping Intimacies ◽

10.1158/1538-7445.am10-754 ◽

2010 ◽

Author(s):

Rakesh K. Srivastava ◽

Chris Jackman ◽

Rachel Davis ◽

Sharmila Shankar

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Death Receptor ◽

Breast Cancer Therapy ◽

Receptor Agonists

Download Full-text

Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review

Bioorganic Chemistry ◽

10.1016/j.bioorg.2017.02.011 ◽

2017 ◽

Vol 71 ◽

pp. 257-274 ◽

Author(s):

A. Jameera Begam ◽

S. Jubie ◽

M.J. Nanjan

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Therapy ◽

Critical Review ◽

Breast Cancer Therapy ◽

Receptor Agonists

Download Full-text

Biomarkers indicate efficacy of breast cancer therapy

Nature India ◽

10.1038/nindia.2014.137 ◽

2014 ◽

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Breast Cancer Therapy

Download Full-text

Age, Tumor Size Predict Failure After Breast Cancer Therapy

Family Practice News ◽

10.1016/s0300-7073(10)71047-1 ◽

2010 ◽

Vol 40 (17) ◽

pp. 12

Author(s):

HEIDI SPLETE

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Breast Cancer Therapy

Download Full-text

(TA)MUC1 as a potential new target for breast cancer therapy

10.1055/s-0040-1718204 ◽

2020 ◽

Author(s):

AS Heimes ◽

P Fries ◽

N Stergiou ◽

R Attariya ◽

A Hasenburg ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Breast Cancer Therapy

Download Full-text

Off-label drug use in breast cancer therapy

10.24292/01.or.300617.5 ◽

2017 ◽

Vol 7 (2) ◽

pp. 83-87

Author(s):

Tomasz Jankowski ◽

Monika Urbaniak

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Drug Use ◽

Breast Cancer Therapy ◽

Download Full-text

Faculty Opinions recommendation of Bisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718089851.793483710 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Cancer Therapy ◽

Meta Analysis ◽

Adjuvant Setting ◽

Breast Cancer Therapy ◽

Download Full-text

Faculty Opinions recommendation of Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726165826.793550720 ◽

2018 ◽

Author(s):

WH Wilson Tang

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Therapy ◽

Cardiac Dysfunction ◽

Breast Cancer Therapy ◽

Double Blind ◽

Double Blind Clinical Trial ◽

Adjuvant Breast Cancer

Download Full-text

Development of targeted Sindbis Virus Vectors for Potential Application to Breast Cancer Therapy

10.21236/ada392586 ◽

2000 ◽

Author(s):

Lesia K. Dropulie

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Potential Application ◽

Sindbis Virus ◽

Breast Cancer Therapy ◽

Download Full-text

Anti-HER2/Toxin Expressing Lymphocytes for Breast Cancer Therapy

10.21236/ada393070 ◽

2000 ◽

Author(s):

Randall Strobe

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Breast Cancer Therapy

Download Full-text

P53 Regulation of Uridine Phosphorylase Activity Pyrimidine Salvage Pathway and Their Effects on Breast Cancer Therapy

10.21236/ada395919 ◽

2001 ◽

Author(s):

Deliang Cao ◽

Giuseppe Pizzorno

Keyword(s):

Breast Cancer ◽

Cancer Therapy ◽

Uridine Phosphorylase ◽

Salvage Pathway ◽

Phosphorylase Activity ◽

Breast Cancer Therapy ◽

Pyrimidine Salvage

Download Full-text